Individuals producing the lowest levels of HbF showed eightfold upregulation of miR-144, suggesting that an miR-144 antagomir or activation of Nrf2 might be clinically useful in the management of sickle-cell disease. Here, NFE2L2 is linked to sickle cell disease.